Rossari Biotech's material subsidiary, Unitop Chemicals Private Limited, has approved the sale of its office premises located in Saki Naka, Mumbai. The transaction, valued at approximately ₹10 crores, was sanctioned by the subsidiary's Board of Directors during a meeting held on April 3, 2026. The completion of this transaction is anticipated by the end of the second quarter of the financial year 2027.
The office premises in question are not currently utilised for any business operations by the subsidiary. Consequently, the sale is not expected to impact the business operations of either Rossari Biotech or its subsidiary, Unitop Chemicals.
Additionally, the sale does not qualify as the sale of an undertaking under Section 180(1)(a) of the Companies Act, 2013. Further details regarding the transaction will be disclosed upon the execution of the agreement, in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).
This article is written by Kinjal and reviewed by Aman Shukla before publication.